Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Atrial Fibrillation Devices Market Size Outlook: How Quickly Will Revenue Expand Through 2030?
The atrial fibrillation devices market size has experienced rapid expansion in recent years. It is projected to increase from $8.6 billion in 2025 to $9.61 billion in 2026, at a compound annual growth rate (CAGR) of 11.7%. The market’s past growth is attributable to factors such as the increasing prevalence of atrial fibrillation, a rising geriatric population, the growing burden of cardiovascular diseases, the expansion of electrophysiology labs, and the wider adoption of implantable cardiac devices.
The atrial fibrillation devices market size is projected to experience substantial growth in the coming years, reaching $14.77 billion by 2030, with a compound annual growth rate (CAGR) of 11.3%. This expansion during the forecast period is driven by advancements in ablation technologies, an increasing reliance on remote patient monitoring, a heightened awareness of stroke prevention, the expansion of ambulatory surgical centers, and technological innovation in mapping and navigation systems. Prominent trends observed in this period include the rising adoption of catheter ablation procedures, the growing utilization of wearable and remote ECG monitoring devices, an increasing demand for minimally invasive AFib treatments, the expansion of left atrial appendage closure device usage, and an improved focus on early detection and long-term rhythm monitoring.
Get A Free Sample Report With In-Depth Market Insights:
Atrial Fibrillation Devices Market Industry Drivers: What’s Behind The Revenue Growth?
The increasing prevalence of cardiovascular ailments is anticipated to drive the expansion of the atrial fibrillation device market in the future. These conditions encompass various disorders impacting the heart and circulatory system, such as heart attacks, strokes, and high blood pressure. The escalation in cardiovascular disease cases stems from a worldwide surge in obesity and diabetes, alongside the widespread embrace of inactive lifestyles and unhealthy eating patterns. Atrial fibrillation (AFib) devices are crucial for handling cardiovascular diseases, as they identify, track, and address abnormal heart rhythms frequently linked to or resulting from existing heart issues. For example, in June 2024, data released by the American Heart Association, a US-based public health organization, indicated that with high blood pressure anticipated to climb from 51.2% to 61.0%, the count of individuals diagnosed with cardiovascular diseases is forecasted to climb from 128 million in 2020 to exceed 184 million by 2050. Consequently, the rising incidence of cardiovascular diseases is fueling the development of the atrial fibrillation device market.
Atrial Fibrillation Devices Market Segment Landscape And Growth Outlook
The atrial fibrillation devices market covered in this report is segmented –
1) By Device Type: Implantable Devices, External Devices, Catheter-Based Devices
2) By Product: Electrophysiology Ablation Catheters, Cardiac Monitors Or Implantable Loop Recorder, Electrophysiology Diagnostic Catheters, Mapping And Recording Systems, Access Devices, Intracardiac Echocardiography, Left Atrial Appendage Closure Devices, Other Products
3) By Technology: Radiofrequency, Cryotherapy, Ultrasound, Other Technologies
4) By Distribution Channel: Direct Sales, Distributors, Online Sales
5) By End-Use: Hospitals, Cardiac Centers, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Implantable Devices: Implantable Cardioverter Defibrillators, Pacemakers, Insertable Cardiac Monitors
2) By External Devices: External Defibrillators, Holter Monitors, Mobile Cardiac Telemetry Devices, Electrocardiogram Monitors
3) By Catheter-Based Devices: Radiofrequency Ablation Catheters, Cryoablation Catheters, Laser Ablation Catheters, Mapping and Navigation Systems, Transseptal Access Devices
#Atrial Fibrillation Devices Market Growth Trends: What’s Shaping The Future Outlook?
Leading companies in the atrial fibrillation devices market are concentrating on technological advancements, such as patient-centric clinical decision support tools, to improve diagnostic precision, personalize treatment approaches, and achieve better patient outcomes. These patient-centric clinical decision support tools are digital solutions that assist healthcare professionals in customizing treatment decisions by analyzing individual patient data. For instance, in August 2023, GE HealthCare Technologies Inc., a US-based medical technology company, launched CardioVisio for Atrial Fibrillation, a digital clinical decision support tool designed to streamline clinician workflows and facilitate precision care for patients with atrial fibrillation. This tool allows healthcare providers to visualize the progression of AFib, including previous diagnoses, treatments, medications, and associated conditions. The platform offers guideline-based therapy recommendations, which helps to reduce diagnostic errors and streamline clinical decision-making. CardioVisio organizes fragmented patient information into an accessible format, thereby easing the burden on medical staff and enabling more timely, personalized, and effective management of atrial fibrillation.
Atrial Fibrillation Devices Market Leading Companies And Competitive Benchmarking
Major companies operating in the atrial fibrillation devices market are Johnson And Johnson Services Inc, Abbott Laboratories, Medtronic Public Limited Company, Koninklijke Philips NV, Boston Scientific Corporation, Shanghai MicroPort EP MedTech Co Ltd, Japan Lifeline Co Ltd, AliveCor Inc, CardioFocus Inc, Imricor Medical Systems Inc, Kardium Inc, Stereotaxis Inc, Volta Medical, Osypka AG, CathRx Ltd, BIOTRONIK SE And Co KG, EP Solutions SA, CardiacSense Ltd, Biosense Webster Inc, Abbott Electrophysiology, Medtronic Cardiac Rhythm And Heart Failure, Boston Scientific Electrophysiology
View The Full Atrial Fibrillation Devices Market Report:
Atrial Fibrillation Devices Market Largest Region By Revenue And Market Share
North America was the largest region in the atrial fibrillation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the atrial fibrillation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
